Literature DB >> 28716781

Incidence and Trends in Hypoglycemia Hospitalization in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study.

Victor W Zhong1, Juhaeri Juhaeri2, Stephen R Cole3, Evangelos Kontopantelis4, Christina M Shay5, Penny Gordon-Larsen1,6,7, Elizabeth J Mayer-Davis8,7.   

Abstract

OBJECTIVE: To determine trends in hospitalization for hypoglycemia in adults with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) in England. RESEARCH DESIGN AND METHODS: Adults with T1DM or T2DM were identified from 398 of the 684 practices within the Clinical Practice Research Datalink, for which linkage to the Hospital Episode Statistics was possible. Hypoglycemia as the primary reason for hospitalization between 1998 and 2013 was extracted. Trends were estimated using joinpoint regression models for adults with T1DM, young and middle-aged adults with T2DM (18-64 years), and elderly adults with T2DM (≥65 years), respectively.
RESULTS: Among 23,246 adults with T1DM, 1,591 hypoglycemia hospitalizations occurred during 121,262 person-years. Among 241,441 adults with T2DM, 3,738 hypoglycemia hospitalizations occurred during 1,344,818 person-years. In adults with T1DM, the incidence increased 3.74% (95% CI 1.70-5.83) annually from 1998 to 2013. In young and middle-aged adults with T2DM, the annual incidence increase was 4.12% (0.61-7.75) from 1998 to 2013. In elderly adults with T2DM, the incidence increased 8.59% (5.76-11.50) annually from 1998 to 2009, and decreased 8.05% (-14.48 to -1.13) annually from 2009 to 2013, but the incidence was still higher in 2013 than 1998 (adjusted rate ratio 3.01 [1.76-5.14]). Trends in HbA1c level did not parallel trends of hypoglycemia hospitalization for both diabetes types. A possible reason for declined hypoglycemia trend in 2009-2013 in elderly adults with T2DM may be continuously decreased sulfonylurea use after 2009, which was not seen in young and middle-aged adults with T2DM.
CONCLUSIONS: Hypoglycemia requiring hospitalization has been an increasing burden in adults with T1DM and T2DM in England in the previous two decades, with the exception of the decline in elderly adults with T2DM starting in 2009.
© 2017 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28716781     DOI: 10.2337/dc16-2680

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  16 in total

1.  Effectiveness of Targeted Insulin-Adherence Interventions for Glycemic Control Using Predictive Analytics Among Patients With Type 2 Diabetes: A Randomized Clinical Trial.

Authors:  Julie C Lauffenburger; Jennifer Lewey; Saira Jan; Sagar Makanji; Christina A Ferro; Alexis A Krumme; Jessica Lee; Roya Ghazinouri; Nancy Haff; Niteesh K Choudhry
Journal:  JAMA Netw Open       Date:  2019-03-01

2.  Associations between glycated hemoglobin and the risks of incident cardiovascular diseases in patients with gout.

Authors:  Likang Li; Gregory Y H Lip; Shuai Li; Jonathan D Adachi; Lehana Thabane; Guowei Li
Journal:  Cardiovasc Diabetol       Date:  2022-07-15       Impact factor: 8.949

Review 3.  The individualisation of glycaemic targets in response to patient characteristics in type 2 diabetes: a scoping review.

Authors:  Samuel J Westall; Ram Prakash Narayanan; Simon Watmough; Greg Irving; Niall Furlong; Sid McNulty; Sumudu Bujawansa; Kevin Hardy
Journal:  Clin Med (Lond)       Date:  2022-04-20       Impact factor: 5.410

4.  Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study.

Authors:  Ronan Roussel; Jean-Pierre Riveline; Eric Vicaut; Gérard de Pouvourville; Bruno Detournay; Corinne Emery; Fleur Levrat-Guillen; Bruno Guerci
Journal:  Diabetes Care       Date:  2021-04-20       Impact factor: 17.152

5.  Occurrence of severe hypoglycaemic events among US youth and young adults with type 1 or type 2 diabetes.

Authors:  Sharon Saydah; Giuseppina Imperatore; Jasmin Divers; Ronny Bell; Leora Henkin; Elizabeth Mayer-Davis; Victor W Zhong; Dana Dabelea; Jean M Lawrence; Catherine Pihoker
Journal:  Endocrinol Diabetes Metab       Date:  2019-01-19

6.  Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016.

Authors:  Colette Mair; Wahyu Wulaningsih; Anita Jeyam; Stuart McGurnaghan; Luke Blackbourn; Brian Kennon; Graham Leese; Robert Lindsay; Rory J McCrimmon; John McKnight; John R Petrie; Naveed Sattar; Sarah H Wild; Nicholas Conway; Ian Craigie; Kenneth Robertson; Louise Bath; Paul M McKeigue; Helen M Colhoun
Journal:  Diabetologia       Date:  2019-05-18       Impact factor: 10.122

7.  Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017.

Authors:  John M Dennis; William E Henley; Andrew P McGovern; Andrew J Farmer; Naveed Sattar; Rury R Holman; Ewan R Pearson; Andrew T Hattersley; Beverley M Shields; Angus G Jones
Journal:  Diabetes Obes Metab       Date:  2019-04-04       Impact factor: 6.577

8.  Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin-treated type 2 diabetes: The Fukuoka Diabetes Registry.

Authors:  Masanori Iwase; Yuji Komorita; Hiroki Fujii; Toshiaki Ohkuma; Hitoshi Ide; Masahito Yoshinari; Yutaro Oku; Taiki Higashi; Udai Nakamura; Takanari Kitazono
Journal:  J Diabetes Investig       Date:  2020-04-26       Impact factor: 4.232

Review 9.  Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies.

Authors:  Guntram Schernthaner; Marie Helene Schernthaner-Reiter
Journal:  Diabetologia       Date:  2018-02-07       Impact factor: 10.122

10.  Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA1c and glucose-lowering drug use before and after hypoglycaemia.

Authors:  Mads Bisgaard Bengtsen; Jakob Schöllhammer Knudsen; Maria Bisgaard Bengtsen; Niels Møller; Reimar Wernich Thomsen
Journal:  Endocrinol Diabetes Metab       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.